Active: new fund Sep 2026 Verified 4 Nov 2026
SR One
Biotechnology venture capital firm that partners with founders to translate science into medicines using a back-and-build approach, with a transatlantic presence. Based in Wayne, PA.
- Type
- VC firm
- Location
- Wayne, Pennsylvania, United States
- Backs
- Biotech and pharma
- Sectors
- Healthtech and life sciences, Biotech
- Fund size / AUM
- $600M SR One Capital Fund III (Form D offering, 2024)
- Latest fund or filing
- 18 Jun 2026
- Portfolio mix
- Biotech and pharma 100% (n=27)
- UK office
- London
- Website
- www.srone.com
Fund filings (SEC Form D)
- Latest fund on file
- SR One Capital Fund III
- Filed
- 18 Jun 2026 (amendment)
- Fund size
- $600M (total offering)
- Fund vehicles filed in the last 12 months
- 1 (includes feeder and parallel vehicles)
See this fund's filings on SEC EDGAR
Contacts on file
For SR One, the paid file holds: 8 named decision-makers with roles; LinkedIn page.
Get US Complete, $197 Free sample
One-time payment. No subscription. No account.
Notable investments
ADARx PharmaceuticalsAirNexis Therapeutics, Inc.AlumisAncora BiotechAntag Therapeutics ApS
Sources
Last checked 4 Nov 2026. Is something wrong? Tell us.
Appears in 10 lists
Healthtech investors in Pennsylvania (16)Venture capital firms in Philadelphia (19)Venture capital firms in Pennsylvania (43)International investors with a UK office (67)Biotech venture capital firms in the US (297)Biotech investors (484)Healthtech venture capital firms in the US (709)Healthtech investors (1,207)Active venture capital firms in the US (1,574)Venture capital firms in the US (2,975)